| Previous Close | 1.4900 |
| Open | 1.4800 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 1.2845 - 1.4800 |
| 52 Week Range | 0.2300 - 1.5000 |
| Volume | 1,675 |
| Avg. Volume | 3,312 |
| Market Cap | 51.803M |
| Beta (3Y Monthly) | 1.41 |
| PE Ratio (TTM) | 483.33 |
| EPS (TTM) | 0.0030 |
| Earnings Date | Nov 3, 2016 - Nov 4, 2016 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 0.70 |
Faris Sleem, editor of The Bowser Report, is a leading specialist in low-priced, micro-cap stocks; indeed, his latest featured recommendation had 2018 revenues of just $3.8 million.
Revenue Growth of 129% to $1.9 MillionOperating Income Growth of 322% to $132,7051st Half 2019 EPS of $0.01 TAMPA, FL, July 29, 2019 -- Trxade Group, Inc. (OTCQB: TRXD), an.
Trxade Group, Inc. (TRXD), Trxade is an integrated pharmaceutical logistical services company that combines a web-based purchasing platform for transactions between independent pharmacies and drug manufacturers, MSO with a specialty pharmacy, and a warehouse and drug delivery service for consumers. Trxade is pleased to announce that the registration statement on Form S-1 (the "S-1 Registration Statement") previously filed with the Securities and Exchange Commission (the "SEC") was declared effective by the SEC today, July 2nd, 2019. This S-1 Registration Statement covers the resale from time to time by the selling shareholders identified in the S-1 Registration Statement for up to 31,949,712 shares of our common stock.
Trxade Group, Inc. (TRXD), Trxade is an integrated pharmaceutical logistical services company that combines a web-based purchasing platform for transactions between independent pharmacists and drug manufacturers, MSO with a Specialty pharmacy. Trxade has warehouse and drug delivery services for consumers further advanced capabilities today by announcing that company’s subsidiary Community Specialty Pharmacy (https://www.comsprx.com ) has secured its certification with LegitScript.
First Quarter Highlights: Company achieves record revenues of $1.512 million in quarter ending March 31, 2019 an increase from $852,923 in quarter ending March 31, 2018 Operating Income Increased to $171,759 ...
NEW YORK, April 23, 2019 -- via NetworkWire - Trxade Group Inc. (OTCQB: TRXD), an integrated drug purchasing and delivery platform that enables trade among healthcare buyers.
TAMPA, Fla., March 26, 2019 -- Trxade Group, Inc., (OTCQB: TRXD) is an integrated drug purchasing and delivery solutions company with a market platform that enables trade among.
Expected to Drive Revenue Growth in 2019 TAMPA, FL, Feb. 25, 2019 -- February 25, 2019 – Trxade Group, Inc. (OTCQB: TRXD) (“Trxade” or the “Company”), an integrated drug.
TAMPA, FL, Feb. 07, 2019 -- Trxade Group, Inc. (OTCQB: TRXD) (“Trxade” or the “Company”), an integrated healthcare platform, announced today its participation in the Healthcare.
A Revolutionary Technology Solution to Empower Independent Retail Pharmacies TAMPA, FL, Jan. 22, 2019 -- Trxade Group, Inc. (OTCQB: TRXD) (“Trxade” or the “Company”), an.
Focused on Increasing Awareness and Enhancing Shareholder Value TAMPA, FL, Jan. 03, 2019 -- Trxade Group, Inc. (OTCQB: TRXD) (“Trxade” or the “Company”), a web-based.
LOS ANGELES, CA / ACCESSWIRE / November 19, 2018 / Trxade Group, Inc., ( OTCQB: TRXD ) the trusted B2B market place for 9,300 registered independent pharmacy customers that enables its customers to quickly ...
Achieved 15% Revenue growth from year-over-year periods and the seventh consecutive quarter of positive operating incomeCompleted a strategic acquisition of a retail specialty.
TAMPA, FL / ACCESSWIRE / October 16, 2018 / Trxade Group, Inc., ( OTCQB: TRXD ) a web-based pharmaceutical sourcing and purchasing platform with 9,300 registered independent pharmacy customers that procure ...
TAMPA, FL / ACCESSWIRE / October 2, 2018 / Trxade Group, Inc., (OTCQB: TRXD) a web-based market platform with 9,300 registered independent pharmacy customers that enables its customers to quickly source and purchase pharmaceuticals, accessories and services from a wide range of manufacturers and drug distributors today announced new enhancements to the trading platform. Jariel Morales, Executive Vice President of Trxade Group said, "As we continue on our path of being a premier healthcare solutions provider, our team has focused on the voice of the customer and expanding our portfolio to provide additional services to our members that increase their bottom line revenue, increase the number of patients they see each month, and provide alternative health solutions to their patient base. New and advanced filters allowing members to select VAWD, VAWD Pending, or Non-VAWD Suppliers and filter their favorite products by Brand or Generic.